Abstract
The present study evaluates the effects of pre-hepatic portal hypertension, induced in rats by partial portal vein ligation, on the responsiveness of rostral (proximal) and caudal (distal) rings from the mesenteric vein. The anatomical origin of the sample influenced the response to vasoconstrictors in sham-operated animals, and this pattern of reactivity was specifically modified in portal-ligated rats. In veins from sham-operated rats, contraction induced by a submaximal concentration of KCl (60 mM) was greater in proximal than in distal rings. Vasopressin and 5-hydroxytryptamine contracted mainly distal rings, methoxamine showed a greater effect on proximal rings, and endothelin-1 and angiotensin-II contracted vein rings independently of their anatomical origin. In veins from portal hypertensive rats, responses to KCl (60 mM) were increased in distal rings, and all rings exhibited enhanced reactivity to vasopressin and 5-hydroxyptyptamine as well as attenuation of the response to methoxamine. Responses to endothelin-1 were decreased in proximal vein rings from portal hypertensive rats whereas responses to angiotensin-II were not influenced by the anatomical origin. Incubation with atropine, propranolol or indomethacin, did not modify the responses to vasopressin and 5-hydroxytryptamine in tissues from either sham-operated or portal hypertensive animals. Likewise, the hyporeactivity to methoxamine and endothelin-1 in rings from portal hypertensive rats persisted in the presence of the nitric oxide inhibitor N G-nitro-l-arginine methyl ester. These results suggest the physiological existence of anatomical differences in the responsiveness to vasoconstrictors throughout the mesenteric vein and that changes in the responsiveness of the mesenteric vein induced by portal hypertension are specific for each agonist and possibly result from individual variations at a receptor or post-receptor level.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benoit JN, Barrowman JA, Harper SL, Kvietys PR, Granger DN (1984) Role of Immoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol 247: G486-G493
Benoit JN, Zimmerman BJ, Premen AJ (1986) Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 251:G674-G677
Bosch J, Pizcueta P, Fen F, Fernández M, Garcia-Pagan JC (1992) Pathophysiology of portal hypertension. Gastroenterol Clin North Am 21:1–61
Bosch J Garcia-Pagán JC, Fen F, Luca A, Fernández M, Pizcueta P, Rodes J (1993) New approaches in the pharmacologic treatment of portal hypertension. J Hepatol 17:S41-S45
Bosch J, Garcia-Pagán JC, Feu F, Rodes J (1994) Portal Hypertension. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz A (eds) The Liver: biology and pathobiology, 3rd edn. Raven New York, pp 1343–1355
Chojkier M, Groszmann RJ (1981) Measurement of portal-systemic shunting in the rat by using labelled microspheres. Am J Physiol 240:G371-G375
Claria J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, Rodes J (1994) Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 20:1615–1621
Cummings SA, Groszmann RJ, Kaumann AJ (1986) Hypersensitivity of mesenteric veins to 5-hydroxytryptamine and ketanserineinduced reduction of portal pressure in portal hypertensive rats. Br J Pharmacol 89:501–513
D'Amico G, Pagliato L, Bosch J (1995) The treatment of portal hypertension. A meta-analytic review. Hepatology 22(I):332–354
Goff JS (1993) Gastroesophageal varices: Pathogenesis and therapy of acute bleeding. Gastroenterol Clin North Am 22:779–799
Grozsmann RJ, Atterbury CE (1982) The pathophysiology of portal hypertension. A basis for classification. Semin Liver Dis 2:177–186
Jensen LS, Juhl CO, Mulvany MJ (1987) Mechanical, morphological and pharmacological properties of oesophageal varices and small mesenteric veins in portal hypertensive rabbits. Acta Physiol Scand 130:649–656
Joh T, Granger DN, Benoit JN (1993) Endogenous vasoconstrictor tone in intestine of normal and portal hypertensive rats. Am J Physiol 11171–11177
Karatapanis S, Mccormick PA, Kakad S, Chin JKT, Islam M, Jeremy J, Harry D, McIntyre N, Burroughs AK, Jacobs M (1994) Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 20:1516–1521
Kiel JW, Pitts JN, Benoit JN, Granger DN, Shepherd AP (1985) Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol 248:G192-G195
Liao JF, Yu PC, Lin HC, Lee FY, Kuo JS, Yang MCM (1994) Study on the vascular reactivity and alpha1-adrenoceptors of portal hypertensive rats. Br J Pharmacol 111:439–444
Matloff DS (1992) Treatment of acute variceal bleeding. Gastroenterol Clin North Am 21:103–118
Mesh CL, Joh T, Korthuis RJ, Granger DN, Benoit JN (1991) Intestinal vascular sensitivity to vasopressin in portal hypertensive rats. Gastroenterology 100:916–921
Motulsky HJ, Ransnas LA (1987) Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J 1:365–374
Pizcueta MP, Casamitjana R, Bosch J (1990) Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats. Role of hyperglucagonism. Am J Physiol 258: G191-G196
Pizcueta MP, Piqué JM, Bosch J, Whittle BJR, Moncada S, Rodes J (1991) Hemodynamic effects of endogenous nitric oxide inhibition in cirrhotic rats. Hepatology 14:301–306
Sieber CC, Groszmann RJ (1992a) Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 103:235–239
Sieber CC, Groszmann RJ (1992b) In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 262:G996-G1001
Sitzmann JV, Li SS, Lin PW (1989) Prostacyclin mediates splachnic vascular response to norepinephrine in portal hypertension. J Surg Res 47:208–211
Sitzmann JV, Li SS, Wu YP, Grozsmann RJ, Bulkley GB (1990) Decreased mesenteric vascular response to Angiotensin II in portal hypertension. J Surg Research 48:341–344
Wu Y, Burns RC, Sitzmann JV (1993) Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 18:1416–1421
Wu ZY, Benoit JN (1994) Vascular NE responsiveness in portal hypertension: role of portal pressure and portosystemic shunting. Am J Physiol 266:H1162-H1168
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moreno, L., Angeles Martínez-Cuesta, M.A., Piqué, J.M. et al. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 354, 474–480 (1996). https://doi.org/10.1007/BF00168439
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168439